In Vitro Diagnostics Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth Opportunity: 2022-2028
See less
In Vitro Diagnostics Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth Opportunity: 2022-2028
The In Vitro Diagnostics Market is segmented by Test Type (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics, Hematology, and Others), by Product Type (Instruments, Reagents, and Others), by Usability Type (Disposable IVD Devices and Reusable IVD Devices), by Application Type (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, and Others), by End-User Type (Diagnostic Laboratories, Hospitals and Clinics, and Others), and by Region (North America [The USA, Canada, and Mexico], Europe [Germany, France, The U.K., Russia, and Rest of Europe], Asia-Pacific [China, Japan, India, South Korea, and Rest of Asia-Pacific], and Rest of the World [Brazil, Saudi Arabia, Israel, and Others]).
The In Vitro Diagnostics Market is segmented by Test Type (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics, Hematology, and Others), by Product Type (Instruments, Reagents, and Others), by Usability Type...
“The In Vitro Diagnostics Market was estimated at USD 100.49 billion in 2021 and is expected to grow at aCAGR of 2.7%during 2022-2028 to reach USD 121.09 billion in 2028”.
In vitro diagnostics are tests that are performed on blood samples or tissues that have been taken from the human body, to detect, treat, and prevent diseases. These tests aid in detecting diseases, infections, and other medical conditions. Common IVD techniques include immunoassays, molecular diagnostics, and clinical chemistry analyses, crucial for accurate diagnosis and patient care.
Market Drivers
The growth of the global IVD market is primarily driven by -
Major factors such as the high prevalence of chronic and infectious diseases.
The rapid development of diagnostic kits for the diagnosis of COVID-19 by key companies.
The growing demand for IVD kits and reagents.
Segments Analysis
Segmentations
List of Sub-Segments
Dominant and Fastest-Growing Segments
Test-Type Analysis
Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics, Hematology, and Others
The Molecular Diagnostics segment accounted for the largest market share in 2021.
Product-Type Analysis
Instruments, Reagents, and Others
The Reagents segment accounted for the largest market share in 2021.
End-User-Type Analysis
Diagnostic Laboratories, Hospitals and Clinics, and Others
The Diagnostic Laboratories segment accounted for the largest IVD market share in 2021.
Application-Type Analysis
Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, and Others
The Infectious Disease segment accounted for the largest market share in 2021.
Regional Analysis
North America, Europe, Asia-Pacific, and Rest of the World
North America accounted for the largest market share in 2021.
By Test Type
“The Molecular Diagnostics sector held the largest share of the market and is anticipated to experience robust growth throughout the forecast period”.
The market is segmented into clinical chemistry, molecular diagnostics, immuno diagnostics, hematology, and others. The Molecular Diagnostics segment accounted for the largest IVD market share of >35% in 2021 and is projected to grow at a healthy CAGR during the forecast period.
Want to get more details about the segmentations? Register Here
By Product Type
“The Reagents segment led the global market and is expected to grow steadily during the forecast period”.
The market is segmented into instruments, reagents, and others. There is an increasing need for reagents to meet the growing demand for diagnostics worldwide, for the diagnosis of COVID-19 infection. The Reagents segment accounted for thelargest market share of >60% in 2021 and is projected to grow at a healthy CAGR during the forecast period.
By End-User Type
“Diagnostic Laboratories hold the largest share of the In Vitro Diagnostics (IVD) marketand are set to grow steadily”.
The market is segmented into diagnostic laboratories, hospitals and clinics, and others. The Diagnostic Laboratories segment accounted for the largest IVD market share of >35% in 2021 and is projected to grow at a healthy CAGR during the forecast period. Major growth factors of the laboratory segment are the growing demand for affordable services, technological advancements, and a rapid increase in awareness about personalized medicines.
By Application Type
“The Infectious Disease segment dominates the market and is projected to grow steadily during the forecast period”.
The market is segmented into infectious disease, diabetes, cancer/oncology, cardiology, autoimmune disease, nephrology, and others. The Infectious Disease segment accounted for the largest market share of >55% in 2021 and is projected to grow at a healthy CAGR during the forecast period. The IVDs facilitate the detection of microorganisms or disease-causing bacteria. HIV/AIDS, TB, hepatitis, and pneumonia are the most frequently occurring life-threatening illnesses.
Regional Analysis
“North America leads the market, expected to grow steadily. Europe and Asia-Pacific also promise significant growth opportunities in the forecast period”.
The market is broken down geographically into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In terms of regions, North America accounted for the largest market share of >40% in 2021 and is projected to grow at a healthy CAGR during the forecast period. It is estimated to be the dominating region in the market over the forecast period on account of its well-established healthcare industry, rising prevalence of chronic diseases in the region, presence of some of the market's major players, and an increasing number of product launches. Europe and Asia-Pacific are also expected to offer substantial growth opportunities during the forecast period.
Want to know which region offers the best growth opportunities?Register Here
Key Players
The following are the key players in the In Vitro Diagnostics (IVD) Market (arranged alphabetically)
Abbott Laboratories
Arkray Inc.
Becton, Dickinson, and Company
Bio-Rad Laboratories, Inc.
Biomerieux SA
Danaher Corporation
F. Hoffmann-La Roche Ltd.
Siemens Healthcare GmbH
Sysmex Corporation
Thermo Fischer Scientific Inc.
Note: The above list does not necessarily include all the top players in the market.
Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com
Report Features
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.
What Deliverables Will You Get in this Report?
Key questions this report answers
Relevant contents in the report
How big is the sales opportunity?
in-depth Analysis of the In Vitro Diagnostics (IVD) Market
How lucrative is the future?
The market forecast and trend data and emerging trends
Which regions offer the best sales opportunities?
Global, regional, and country-level historical data and forecasts
Which are the most attractive market segments?
Market segment analysis and Forecast
Which are the top players and their market positioning?
Porter’s five forces analysis, PEST analysis, Life cycle analysis
What are the factors affecting the market?
Drivers & challenges
Will I get the information on my specific requirement?
10% free customization
Research Methodology
This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.
More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.
We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.
Report Customization Options
With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:
Company Profiling
Detailed profiling of additional market players (up to three players)
SWOT analysis of key players (up to three players)
Competitive Benchmarking
Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.
Custom Research:
Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.
LOADING
LOADING
×
Please enter your contact details. It will allow our analysts to reach out to you.
In Vitro Diagnostics are tests that are performed on blood samples or tissues that have been taken from the human body, to detect, treat, and prevent diseases.
The growth of the in vitro diagnostics market is primarily driven by - Major factors such as the high prevalence of chronic and infectious diseases. The rapid development of diagnostic kits for the diagnosis of COVID-19 by key companies. The growing demand for IVD kits and reagents is likely to propel the growth of the in vitro diagnostics market during the forecast period.
The key players operating in the market are Abbott Laboratories, Arkray Inc., Becton, Dickinson, and Company, Biomerieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare GmbH, Sysmex Corporation, Thermo Fischer Scientific Inc.